Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) delivers mission-critical technology and engineering solutions to defense, intelligence, and healthcare sectors. This news hub provides investors with essential updates about contract awards, strategic partnerships, and operational developments impacting this Fortune 500 leader.
Access timely press releases and analysis covering Leidos' defense modernization initiatives, cybersecurity advancements, and health IT innovations. Our curated collection helps stakeholders track progress in key areas like geospatial intelligence, digital transformation projects, and government contracting milestones.
Find updates on quarterly earnings, major Department of Defense contracts, and research breakthroughs in secure communications technology. All content is verified through primary sources to ensure accuracy for financial decision-making.
Bookmark this page for centralized access to Leidos' latest achievements in supporting national security infrastructure and advancing critical healthcare systems through technological innovation.
Leidos (NYSE: LDOS) has initiated the 'Move the Needle' sweepstakes, offering $1 million in prizes to encourage COVID-19 vaccinations among its employees. The program, announced on July 7, 2021, will award ten employees with their annual salary, drawn from approximately 35,000 eligible full-time U.S. employees. This initiative is part of Leidos' broader mission to enhance public health and safety. The sweepstakes runs from June 28 to October 29, 2021, highlighting the company's commitment to investing in its workforce to promote vaccination efforts.
Leidos (NYSE:LDOS) announces leadership changes effective July 5, aimed at optimizing internal processes and talent development. Paul Engola is appointed EVP, National Security Space, while George Reiter becomes acting CHRO. Jim Cantor will retire, leading to the creation of a Corporate Operations role, with Vicki Schmanske stepping in as EVP. Roy Stevens will replace Vicki as president of the Intelligence Group. CEO Roger Krone emphasizes the importance of flexibility to address customer needs in evolving markets. Leidos reported annual revenues of $12.30 billion for FY 2021.
Leidos (NYSE:LDOS) has secured a $2.5 billion contract from NASA for the Advanced Enterprise Global Information Technology Solutions (AEGIS) project. This contract spans 10 years if all options are exercised and aims to enhance NASA's telecommunications, cloud, and data center services across all facilities. Leidos will provide critical support for NASA’s IT infrastructure, ensuring mission-critical operations, including cybersecurity and emergency systems. This award follows Leidos' ongoing collaboration with NASA through its NEST contract, supporting the agency's overall IT operations.
Leidos (NYSE: LDOS) has scheduled its second quarter 2021 earnings conference call for August 3, 2021, at 8 a.m. ET. The call will follow an earnings press release issued earlier that day. Interested parties can listen via telephone or through a live stream on the company's Investor Relations website. A replay will be accessible from August 3 at 11:30 a.m. ET until August 10 at 11:59 p.m. ET. Leidos reported approximately $12.30 billion in annual revenues for the fiscal year ending January 1, 2021.
Leidos (NYSE: LDOS) has been awarded a prime contract valued at $950 million by the U.S. Air Force to deliver solutions for aviation requirements over a 13-year period. This indefinite delivery/indefinite quantity contract includes a 10-year ordering period and an additional 3-year performance period. Leidos will enhance ISR capabilities and support the Air Force's efforts in ensuring multi-domain dominance. The work will be conducted globally, benefiting U.S. and allied forces.
Leidos (NYSE: LDOS) has secured a prime contract with the Transportation Security Authority (TSA) valued at $470.7 million to assist in deploying Transportation Screening Equipment (TSE) across U.S. federalized airports. This indefinite delivery/indefinite quantity contract will enable Leidos to conduct surveys, provide design support, and oversee the installation, relocation, and removal of screening equipment. Leidos has previously supported TSA for over 12 years, enhancing operational efficiency and safety at airports and special events.
Leidos has been awarded a prime contract by the CDC to provide bioinformatics and scientific computing support services, valued at over $13 million over five years. This contract enhances CDC's capacity in handling large datasets and high-performance computing for health-related research. The work will be primarily based in Atlanta, Georgia.
Liz Porter, Leidos Health Group president, emphasized the importance of this collaboration in investigating infectious pathogens and advancing public health.
Leidos Holdings has extended its offers for the exchange of various notes totaling $2.25 billion, including 2.950% Notes due 2023 and others, to expire on June 21, 2021. This extension is due to the announcement that June 18 will be a federal holiday. As of June 17, 2021, the company reported significant tendering amounts: 59.7% for the 2023 Notes and over 85% for the 2025 Notes. Other notes tendered include 70.1% for the 2030 Notes and 81.1% for the 2031 Notes. Citibank is the exchange agent for the offers.
Leidos (NYSE: LDOS) has secured a prime contract from the U.S. Army for commercial health services to military reserve forces, valued at $999 million if all options are exercised. This contract spans a one-year base period, with four additional one-year options. Leidos will collaborate with the Defense Health Agency to meet health requirements for service members before, during, and after deployment. Liz Porter, the Health Group president, emphasized the commitment to serving military reservists, while CEO Larry Schaefer stressed the dedication to innovation and customer service in healthcare.
Leidos (NYSE: LDOS) announced its advancement into the final phase of the USSOCOM's Armed Overwatch aircraft prototype program alongside Paramount USA and Vertex. The team has been awarded $19.3 million for prototype demonstrations, focusing on the Bronco II aircraft, which boasts mission flexibility through its Interchangeable Multi-Mission System Bay. Leidos' team aims to showcase the Bronco II's capabilities for ISR, SCAR, and CAS missions. The program is critical for future military operational requirements, showcasing Leidos' ongoing commitment to innovative defense solutions.